Hao-Wen Sim

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma

C. Gedye, A. Heimberger, J. Simes, 2023, Neuro-oncology advances.

Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play.

L. Satgunaseelan, B. Shivalingam, K. Alexander, 2023, Pathology.